The seven types of cancer linked to drinking alcohol
The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link between drinking and cancer. Alcohol causes 800,000 deaths across Europe each ...
Lung cancer rising among non-smokers — here's why
The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising driver of the disease and other risk factors.
American Cancer Society3d
Can Aspirin Help Reduce Your Cancer Risk?
Taking a low dose of daily aspirin is known to have some health benefits. For example, it can help reduce the risk of heart ...
Frontiers2d
Strategies to Improve Awareness and Management of Cancer Risk Factors and Screenings
Cancer continues to be a leading cause of mortality globally, claiming approximately 10 million lives each year. While the ...
Daily Express3d
The red flag symptom of cancer that can appear when you speak - how to spot it
Health bodies have warned that a red flag warning sign of a deadly disease could appear while speaking. According to experts, a hoarse or croaky voice could be a symptom of cancer. There are more ...
Science Daily3d
Cancer News
Feb. 19, 2025 — Breast cancer incidence trends in U.S. women under 40 vary by geography and supports incorporating location information with established risk factors into risk prediction ...
Medical News Today2d
Everything you need to know about colon cancer
According to the ACS, researchers are unsure of the exact cause of colon cancer, but certain factors may increase the risk. Cancer happens as a result of changes in DNA within cells. Certain genes ...
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...
Merus N.V.: Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
This marks the second BTD for petosemtamab in HNSCCUTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025(Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length mult ...